The metabolic abnormalities of type 2 diabetes can be reversed reproducibly by bariatric surgery. By quantifying the major
pathophysiological abnormalities in insulin secretion and insulin action after surgery, the sequence of events leading to
restoration of normal metabolism can be defined. Liver fat levels fall within days and normal hepatic insulin sensitivity
is restored. Simultaneously, plasma glucose levels return towards normal. Insulin sensitivity of muscle remains abnormal,
at least over the weeks and months after bariatric surgery. The effect of the surgery is explicable solely in terms of energy
restriction. By combining this information with prospective observation of the changes immediately preceding the onset of
type 2 diabetes, a clear picture emerges. Insulin resistance in muscle, caused by inherited and environmental factors, facilitates
the development of fatty liver during positive energy balance. Once established, the increased insulin secretion required
to maintain plasma glucose levels will further increase liver fat deposition. Fatty liver causes resistance to insulin suppression
of hepatic glucose output as well as raised plasma triacylglycerol. Exposure of beta cells to increased levels of fatty acids,
derived from circulating and locally deposited triacylglycerol, suppresses glucose-mediated insulin secretion. This is reversible
initially, but eventually becomes permanent. The essential time sequence of the pathogenesis of type 2 diabetes is now evident.
Muscle insulin resistance determines the rate at which fatty liver progresses, and ectopic fat deposition in liver and islet
underlies the related dynamic defects of hepatic insulin resistance and beta cell dysfunction. These defects are capable of
dramatic reversal under hypoenergetic feeding conditions, completely in early diabetes and to a worthwhile extent in more
established disease.
Keywords Bariatric surgery - Beta cell - Hepatic glucose output - Hepatic insulin resistance - Non-alcoholic fatty liver - Muscle insulin resistance - Type 2 diabetes